NEW DOSAGE REGIMEN IN CASE OF CONCURRENT INTAKE OF GABAPENTIN WITH FOOD AND AN INCREASED ORAL BIOAVAILABILITY THEREWITH
摘要
<p>The present invention relates to the use of a gabapentin containing controlled-release oral dosage form for the manufacture of a medicament for once-dailly administration and consuming food within one hour after gabapentin intake for treating conditions for which gabapentin is indicated.</p>
